Fall 2021 Biotechnology Symposium

Published on :

Engage with representatives from MC Biotech, Frederick Community College Biotechnology, and UMBC TLST and biotechnology industry leaders through our Mondays at 4 pm webinar series!

This semester-long symposium will take place online (via Zoom) from 4:00 – 4:45 pm on select Monday afternoons throughout the semester. Sessions will focus on a variety of topics related to biotechnology in a pandemic.

Fall 2021 Biotechnology Symposium

Published on :

Engage with representatives from MC Biotech, Frederick Community College Biotechnology, and UMBC TLST and biotechnology industry leaders through our Mondays at 4 pm webinar series!

This semester-long symposium will take place online (via Zoom) from 4:00 – 4:45 pm on select Monday afternoons throughout the semester. Sessions will focus on a variety of topics related to biotechnology in a pandemic.

5 Questions with Azita Adli, MS, MBA, Manager, QA Systems, GSK

Published on :

Azita Adli is a passionate, innovative, and quality-minded professional with 10+ years of experience within the pharmaceutical industry. Azita has held roles within production, investigation, quality systems, and central quality throughout her career, supporting sites within GlaxoSmithKline’s (GSK’s) Pharmaceutical Supply Chain.

5 Questions with KaShauna G. Rohlehr, Associate Director of Alliance, Program, and Project Management, GlaxoSmithKline

Published on :

KaShauna G. Rohlehr is a highly motivated, results-driven technical and project management professional with 16+ years of experience in the pharmaceutical industry. Over her career, she has held positions within production, quality, technical, and supply chain organizations supporting vaccines and biopharmaceuticals manufacturing. She has been employed with GlaxoSmithKline (GSK) for 11 years, where she is currently Associate Director of Alliance, Program, and Project Management.

GSK to support manufacture of Novavax’ COVID-19 vaccine

Published on :

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, GSK and the UK Government Vaccines Taskforce announced that they have reached an agreement in principle to support manufacturing of up to 60 million doses of Novavax’ COVID-19 vaccine candidate (NVX-CoV2373) for use in the UK. GSK will provide ‘fill and finish’ manufacturing capacity at its Barnard Castle facility in the North East of England beginning as early as May 2021, with a rapid technology transfer between the two companies beginning immediately. GSK and Novavax will negotiate a final agreement to include additional terms and conditions.

Black Women In Bio Making an Impact

Black Women in Bio
Published on :

Its Women’s History Month and being on the heels of Black History Month, BioBuzz is highlighting three successful black women in industry to straddle the importance of both.

2020’s Top 10 Most Read News Stories from the BioHealth Capital Region

Published on :

2020 found the United States embroiled in a chaotic political environment, reckoning with social unrest and racial injustice, and voting in one of the most consequential presidential elections in the country’s history.